Compare · DHR vs QSI
DHR vs QSI
Side-by-side comparison of Danaher Corporation (DHR) and Quantum-Si Incorporated (QSI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and QSI operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $123.97B, about 597.9x QSI ($207.3M).
- Over the past year, DHR is down 12.1% and QSI is down 23.5% - DHR leads by 11.4 points.
- DHR has been more active in the news (20 items in the past 4 weeks vs 12 for QSI).
- DHR has more recent analyst coverage (25 ratings vs 4 for QSI).
- Company
- Danaher Corporation
- Quantum-Si Incorporated
- Price
- $175.13-2.12%
- $0.96-2.77%
- Market cap
- $123.97B
- $207.3M
- 1M return
- -8.20%
- +28.14%
- 1Y return
- -12.08%
- -23.46%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 20
- 12
- Recent ratings
- 25
- 4
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Quantum-Si Incorporated
Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. The company's technology has the applications in proteomics, single cell, transcriptomics, genomics, metabolomics, and drug testing and screening fields. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4Catalyzer Corporation.
Latest DHR
- SEC Form CERT filed by Danaher Corporation
- SEC Form 8-A12B filed by Danaher Corporation
- SEC Form 8-K filed by Danaher Corporation
- Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
- SEC Form 4 filed by Director Sanders A Shane
- SEC Form 4 filed by Director Stevens Raymond C
- SEC Form 4 filed by Director List Teri
- SEC Form 4 filed by Director Zerhouni Elias A.
- SEC Form 4 filed by Director Dewan Feroz
- SEC Form 4 filed by Director Filler Linda
Latest QSI
- Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
- Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
- SEC Form 4 filed by Keyes Jeffry R.
- SEC Form 4 filed by Hawkins Jeffrey Alan
- SEC Form 144 filed by Quantum-Si Incorporated
- SEC Form 144 filed by Quantum-Si Incorporated
- Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
- Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting
- Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)